News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WEISS FRED G
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/03/2021 |
4
| WEISS FRED G (Director) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 5,506 shares
@ $3.31, valued at
$18.2k
|
|
| 07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| WEISS FRED G (Director) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 5,505 shares
@ $4.46, valued at
$24.6k
|
|
| 05/22/2020 |
4
| WEISS FRED G (Director) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 38,716 shares
@ $0
Paid exercise price by delivering 17,778 shares
@ $4.6, valued at
$81.8k
|
|
| 01/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| WEISS FRED G (Director) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 37,037 shares
@ $0 |
|
| 01/28/2019 |
4
| WEISS FRED G (Director) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 34,403 shares
@ $0 |
|
| 05/04/2018 |
4
| WEISS FRED G (Director) has filed a Form 4 on Allergan plc|
Txns:
| Granted 1,985 shares
@ $151.07, valued at
$299.9k
|
|
| 05/05/2017 |
4
| WEISS FRED G (Director) has filed a Form 4 on Allergan plc |
| 08/09/2016 |
4
| WEISS FRED G (Director) has filed a Form 4 on Allergan plc |
| 05/09/2016 |
4
| WEISS FRED G (Director) has filed a Form 4 on Allergan plc|
Txns:
| Granted 1,188 shares
@ $210.34, valued at
$249.9k
|
|
| 06/08/2015 |
4
| WEISS FRED G (Director) has filed a Form 4 on Actavis plc|
Txns:
| Paid exercise price by delivering 549 shares
@ $303.38, valued at
$166.6k
Granted 826 shares
@ $302.3, valued at
$249.7k
|
|
| 05/13/2014 |
4
| WEISS FRED G (Director) has filed a Form 4 on Actavis plc|
Txns:
| Granted 1,142 shares
@ $197.05, valued at
$225k
|
|
| 11/18/2013 |
4
| WEISS FRED G (Director) has filed a Form 4 on Actavis plc|
Txns:
| Sold 3,000 shares
@ $164.15, valued at
$492.5k
|
|
| 10/03/2013 |
4
| WEISS FRED G (Director) has filed a Form 4 on Actavis plc|
Txns:
| Granted 27,275 shares
@ $0 |
|
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/31/2012 |
4
| WEISS FRED G (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 30,000 shares
@ $78.78, valued at
$2.4M
Exercised 30,000 options to buy
@ $36.57, valued at
$1.1M
|
|
| 05/14/2012 |
4
| WEISS FRED G (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 2,887 shares
@ $0 |
|
| 05/17/2011 |
4
| WEISS FRED G (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 3,177 shares
@ $0 |
|
| 12/17/2010 |
4
| WEISS FRED G (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 711 shares
@ $51.05, valued at
$36.3k
Sold 200 shares
@ $51.045, valued at
$10.2k
Sold 3,507 shares
@ $51.04, valued at
$179k
Sold 3,210 shares
@ $51.03, valued at
$163.8k
Sold 200 shares
@ $51.025, valued at
$10.2k
Sold 4,210 shares
@ $51.02, valued at
$214.8k
Sold 9,010 shares
@ $51.01, valued at
$459.6k
Sold 8,952 shares
@ $51, valued at
$456.6k
Exercised 30,000 options to buy
@ $48.48, valued at
$1.5M
|
|
| 05/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|